Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.7943
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
0.8100
+0.0157 (1.98%)
Pre-market: Sep 8, 2026, 7:00 AM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $10 million as of September 4, 2026. Its market cap has increased by 12.21% in one year.
Market Cap
10.00M
Enterprise Value
-31.23M
1-Year Change
12.21%
Ranking
Category
Stock Price
$0.79
ChartMarket Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $10.00M, a decrease of -47.18%. That is a compound annual growth rate of -13.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 10.00M | 67.64% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 11.02M |
| Xenetic Biosciences | 10.94M |
| Azitra | 10.88M |
| GT Biopharma | 10.87M |
| Lunai Bioworks | 10.84M |
| Vistagen Therapeutics | 10.77M |
| Senti Biosciences Holdings | 10.36M |
| CytoMed Therapeutics | 10.19M |